Last patient last visit in randomized, double-blind, SIGNAL-AD Phase 2a study of pepinemab treatment for Alzheimer’s Disease is scheduled for early June 2024 ROCHESTER, N.Y., May 15, 2024 (GLOBE NEWSWIRE) -- Vaccinex, Inc. (Nasdaq: VCNX), a clinical-stage biotechnology company pioneering a differentiated approach to treating neurodegenerative disease and cancer through the inhibition of Semaphorin 4D (SEMA4D),…
Tue, 23 Jul 2024 17:00:00 GMT Does your organization or business have an announcement to promote? The Marietta Daily Journal's self-service Press Release Portal can get your organization's announcement the placement it needs.
Fri, 19 Jul 2024 03:33:00 GMT Nonperforming portfolio loans and leases were $606 million in the current quarter, with the resulting NPL ratio of 0.52%. Compared to the prior quarter, NPLs decreased $102 million with the NPL ratio ...
Thu, 18 Jul 2024 17:00:00 GMT Cell Reports is an open-access journal from Cell Press that publishes high-quality papers across the entire life sciences spectrum. The primary criterion for publication in Cell Reports ...
Sun, 14 Jul 2024 17:00:00 GMT Notable findings include Off Plan properties making up 63% of all property sales Dubai, UAE: haus & haus Real Estate has just published its industry leading Dubai Area Reports for Q2 ... The contents ...
Sat, 13 Jul 2024 11:57:00 GMT Mahmoud laid out in a press release that "only hundreds of places" remain in adult male prisons and that U.K. prisons have operated at "over 99% capacity since the start of 2023," with space ...
